MG
AUGX

Michael Gelband’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Michael Gelband’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,155
Closed -$50K – 2092
2024
Q1 		$50K Sell
12,155
-7,425
-38% -$33.2K ﹤0.01% 1434
2023
Q4 		$115K Buy
+19,580
New +$103K ﹤0.01% 1345

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return

Michael Gelband's AUGX Position: Q2 2024 in Review

Michael Gelband sold out of Augmedix, Inc. Common Stock (AUGX) in Q2 2024, closing a stake of 12,155 shares — an estimated $50K sold.

Michael Gelband first reported a position in AUGX in Q4 2023 and held it in 2 quarters. The position peaked at $115K in Q4 2023. 52 funds tracked by Wall St. Rank hold AUGX as of Q2 2024.

  • Michael Gelband reported no remaining Augmedix, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Michael Gelband sold 12,155 Augmedix, Inc. Common Stock shares in Q2 2024, an estimated $50K.
  • Michael Gelband first reported a position in Augmedix, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • Michael Gelband's Augmedix, Inc. Common Stock position peaked at $115K in Q4 2023.
  • 52 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q2 2024.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.